Showing results (51-60 of 179) with videos related to
Sort By:
Pageof 18
Nephron|January 1, 1991
Pharmacokinetics of a low molecular weight heparin (Fraxiparine) in various stages of chronic renal failureC Goudable, S Saivin, G Houin, et al.British Journal of Haematology|January 1, 1985
Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusionsF Fernandez, C Goudable, P Sie, et al.Blood|October 15, 1994
Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: comparison with CY216D Carrie, C Caranobe, S Saivin, et al.Thrombosis and Haemostasis|August 1, 1994
Pharmacological properties of CY 216 and of its ACLM and BCLM components in the rabbitV Peyrou, J C Lormeau, C Caranobe, et al.Thrombosis and Haemostasis|April 8, 1988
Pharmacokinetics of dermatan sulfate in the rabbit after intravenous injectionF Dol, G Houin, D Dupouy, et al.Blood|October 1, 1989
Pharmacodynamics and pharmacokinetics of dermatan sulfate in humansF Dol, G Houin, M Rostin, et al.Thrombosis and Haemostasis|October 31, 1988
Further studies on the mechanisms for the antithrombotic effects of sulfated polysaccharides in rabbitsF A Ofosu, F Fernandez, N Anvari, et al.Scandinavian Journal of Clinical and Laboratory Investigation|February 1, 1987
Plasma fibrinolytic activity in a group of hypogonadic menA Bennet, P Sie, P Caron, et al.European Journal of Clinical Investigation|December 1, 1986
Heparin half-life and sensitivity in normal subjects and in patients affected by deep vein thrombosisS Benchekroun, B Eychenne, O Mericq, et al.Haemostasis|October 1, 1996
New antithrombotic agents for the prevention and treatment of deep vein thrombosisB BoneuPageof 18